Suppr超能文献

靶向消融稳定的心房颤动源可提高高危患者的成功率:CONFIRM 试验的子研究。

Targeted ablation at stable atrial fibrillation sources improves success over conventional ablation in high-risk patients: a substudy of the CONFIRM Trial.

机构信息

University of California and Veterans' Affairs Medical Centers, San Diego, California, USA.

出版信息

Can J Cardiol. 2013 Oct;29(10):1218-26. doi: 10.1016/j.cjca.2013.07.672. Epub 2013 Aug 30.

Abstract

BACKGROUND

Pulmonary vein (PV) isolation has disappointing results in patients with obesity, heart failure, obstructive sleep apnea (OSA) and enlarged left atria (LA), for unclear reasons. We hypothesized that these comorbidities may cause higher numbers or non-PV locations of atrial fibrillation (AF) sources, where targeted source ablation (focal impulse and rotor modulation [FIRM]) should improve the single-procedure success of ablation.

METHODS

The Conventional Ablation of AF With or Without Focal Impulse and Rotor Modulation (CONFIRM) trial prospectively enrolled 92 patients at 107 AF ablation procedures, in whom computational mapping identified AF rotors or focal sources. Patients underwent FIRM plus conventional ablation (FIRM-guided), or conventional ablation only, and were evaluated for recurrent AF quarterly with rigourous, often implanted, monitoring. We report the n = 73 patients undergoing first ablation in whom demographic information was available (n = 52 conventional, n = 21 FIRM-guided).

RESULTS

Stable sources for AF were found in 97.1% of patients. The numbers of concurrent sources per patient (2.1 ± 1.1) rose with LA diameter (P = 0.021), lower left ventricular ejection fraction (P = 0.039), and the presence of OSA (P = 0.002) or hypomagnesemia (P = 0.017). Right atrial sources were associated with obesity (body mass index ≥ 30; P = 0.015). In patients with obesity, hypertension, OSA, and LA diameter > 40 mm, single-procedure freedom from AF was > 80% when FIRM-guided was used vs. < 50% when conventional ablation was used (all; P < 0.05).

CONCLUSIONS

Patients with "difficult to treat" AF exhibit more concurrent AF sources in more widespread biatrial distributions than other patients. These mechanisms explain the disappointing results of PV isolation, and how FIRM can identify patient-specific AF sources to enable successful ablation in this population.

摘要

背景

肺静脉(PV)隔离在肥胖、心力衰竭、阻塞性睡眠呼吸暂停(OSA)和左心房(LA)增大的患者中效果不佳,原因尚不清楚。我们假设这些合并症可能导致更多的房颤(AF)源或非 PV 位置,在这些位置进行靶向源消融(局灶冲动和转子调制[FIRM])应该提高消融的单次手术成功率。

方法

常规消融房颤伴或不伴局灶冲动和转子调制(CONFIRM)试验前瞻性纳入了 92 名患者的 107 次房颤消融手术,其中计算映射识别房颤转子或局灶源。患者接受 FIRM 加常规消融(FIRM 引导)或仅常规消融,并通过严格、常植入的监测每季度评估复发性 AF。我们报告了 n = 73 名接受首次消融的患者的信息(n = 52 例常规消融,n = 21 例 FIRM 引导)。

结果

97.1%的患者发现稳定的房颤源。每位患者并发源的数量(2.1 ± 1.1)随左心房直径增加(P = 0.021)、左心室射血分数降低(P = 0.039)、OSA 存在(P = 0.002)或低镁血症(P = 0.017)而增加。右房源与肥胖(体重指数≥30;P = 0.015)有关。在肥胖、高血压、OSA 和 LA 直径>40mm 的患者中,当使用 FIRM 引导时,单次手术 AF 无复发率>80%,而当使用常规消融时<50%(均为 P<0.05)。

结论

“难以治疗”的 AF 患者比其他患者表现出更多的并发 AF 源,且分布更广泛。这些机制解释了 PV 隔离效果不佳的原因,以及 FIRM 如何识别特定于患者的 AF 源,从而使该人群的消融成功。

相似文献

引用本文的文献

1
Right atrial strain in atrial fibrillation: the hidden side of the moon.心房颤动中的右心房应变:被忽视的一面。
Front Cardiovasc Med. 2025 May 30;12:1578524. doi: 10.3389/fcvm.2025.1578524. eCollection 2025.
2
Integrated Management of Persistent Atrial Fibrillation.持续性心房颤动的综合管理
Biomedicines. 2025 Jan 2;13(1):91. doi: 10.3390/biomedicines13010091.
5
New Technologies In Atrial Fibrillation Ablation.心房颤动消融新技术
J Atr Fibrillation. 2014 Aug 31;7(2):1022. doi: 10.4022/jafib.1022. eCollection 2014 Aug-Sep.
7
Mechanisms Underlying AF: Triggers, Rotors, Other?房颤的潜在机制:触发因素、转子,还是其他?
Curr Treat Options Cardiovasc Med. 2015 Apr;17(4):371. doi: 10.1007/s11936-015-0371-4.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验